Efficacy of adalimumab therapy in patients with Crohn's disease who were unresponsive to or intolerant of infliximab: 6 years of experience in a single gastroenterology center.

被引：0
|
作者：
Shafran, I [1 ]
Cangemi, D. [1 ]
Burgunder, P. [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [11] Long-term efficacy and safety of adalimumab treatment in a single-center cohort of Crohn's disease patients who failed to infliximab treatment
    Karmiris, Konstantions
    Noman, Maja
    Schnitzler, Fabian
    Fidder, Herma
    Koutroubakis, Ioannis E.
    Kouroumalis, Elias
    Vermeire, Severine
    Van Assche, Geri A.
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2008, 134 (04) : A658 - A658
  • [12] Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study
    Zorzi, F.
    Zuzzi, S.
    Onali, S.
    Calabrese, E.
    Condino, G.
    Petruzziello, C.
    Ascolani, M.
    Pallone, F.
    Biancone, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1397 - 1407
  • [13] ADALIMUMAB THERAPY FOR INFLIXIMAB FAILURES IN CROHN'S DISEASE. A SINGLE-CENTRE UK EXPERIENCE
    Sprakes, M. B.
    Ford, A. C.
    Warren, L.
    Greer, D.
    Donnellan, C. F.
    Jennings, J. S. R.
    Everett, S. M.
    Hamlin, P. J.
    GUT, 2010, 59 : A99 - A100
  • [14] EFFICACY AND SAFETY OF INFLIXIMAB AND ADALIMUMAB IN CROHN'S DISEASE PATIENTS IN A SINGLE IBD CENTER: A RETROSPECTIVE REAL-LIFE STUDY
    Desideri, F.
    Pagnini, C.
    Menasci, F.
    Capasso, M.
    Corleto, V. D.
    Delle Fave, G.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E199 - E200
  • [15] ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS
    Tambasco, R.
    Gionchetti, P.
    Straforini, G.
    Brugnera, R.
    Calabrese, C.
    Poggioli, G.
    Laureti, S.
    Rizzello, F.
    Campieri, M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S128 - S128
  • [16] Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres
    Tursi, Antonio
    Elisei, Walter
    Picchio, Marcello
    Penna, Antonio
    Lecca, Piera Giuseppina
    Forti, Giacomo
    Giorgetti, GianMarco
    Faggiani, Roberto
    Zampaletta, Costantino
    Pelecca, Giorgio
    Brandimarte, Giovanni
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : 485 - 490
  • [17] Efficacy and safety of infliximab versus adalimumab in the treatment of Crohn's disease: The McGill Experience
    Al-Taweel, T.
    Strohl, M.
    Kopylov, U.
    Paradis-Suprenant, L.
    Almaimany, M.
    Martel, M.
    Bitton, A.
    Afif, W.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S369 - S369
  • [18] Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    Vander Cruyssen, B.
    Gils, A.
    De Vos, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 15 - 21
  • [19] Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. -C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    De Vos, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S274
  • [20] Durability of Infliximab in Crohn's Disease: A Single-Center Experience
    Gonzaga, Jason E.
    Ananthakrishnan, Ashwin N.
    Issa, Mazen
    Beaulieu, Dawn B.
    Skaros, Sue
    Zadvornova, Yelena
    Johnson, Kathryn
    Otterson, Mary F.
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : 1837 - 1843
12345